Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Robotic Exoskeleton Gait Training With and Without Brain-Computer Interface Control After Stroke

9. august 2026 oppdatert av: Taichung Veterans General Hospital

Comparison of the Therapeutic Effects Between Traditional and Brain-Computer Interface-Controlled Exoskeleton Gait Training in Post-Stroke Patients: A Randomized Comparative Study

After a stroke, many people have trouble walking. One way to practice walking again is with a wearable robot, called an exoskeleton, that supports the legs and guides them through a walking pattern. In most systems, a therapist or a sensor decides when each step starts.

This study looked at whether it helps to let a person's own brain activity start each step instead. Sensors placed on the scalp recorded brain signals. A computer read these signals and told the robot when to take a step. This way of controlling a device is called a brain-computer interface.

People who had a stroke within the past year took part. They were placed by chance into one of two groups. One group practiced walking with the robot in the usual way. The other group practiced with the robot controlled by their own brain signals. Both groups trained twice a week for 4 weeks.

Before and after the training, the study team measured how far each person could walk in 6 minutes, how long it took to stand up and walk a short distance and sit down again, how strong the knee muscles were, and how each person rated their own health and well-being. The study compared how much the two groups improved.

Studieoversikt

Studietype

Intervensjonell

Registrering (Faktiske)

42

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Taichung, Taiwan, 407219
        • Taichung Veterans General Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Age 30 to 80 years
  • Unilateral lower-limb weakness attributable to a stroke sustained within the previous year
  • Able to complete the Timed Up and Go (TUG) test at baseline
  • Able to follow training instructions
  • Provided written informed consent

Exclusion Criteria:

  • Baseline Timed Up and Go (TUG) time of less than 20 seconds
  • Significant pain in the lower limbs
  • Prior lower-limb surgery
  • Neuromuscular disease affecting gait
  • Cardiopulmonary condition contraindicating gait training
  • Cognitive or cooperative deficits preventing the participant from following training instructions
  • Inability to perform the Timed Up and Go (TUG) test at baseline

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Konvensjonell
Powered lower-limb exoskeleton gait training, twice weekly for 4 weeks. Each session included sit-to-stand, walking, and stand-to-sit phases. Phase transitions were triggered externally by a trained study assistant. No EEG decoding was used.
Eksperimentell: BCI-Controlled
Same exoskeleton training schedule and phases. Each session began with a 6-minute EEG decoder calibration (theta, movement-related cortical potential, alpha). Each phase transition was triggered in a closed loop by the participant's decoded intent.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in 6-Minute Walk Test (6MWT) distance
Tidsramme: Baseline and 4 weeks (immediately before and after the 4-week training program)
Distance walked in 6 minutes along a flat 30-meter indoor corridor, recorded in meters. Participants were instructed to cover as much distance as possible. The same corridor was used for all assessments at both time points. Greater distance indicates better walking capacity.
Baseline and 4 weeks (immediately before and after the 4-week training program)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in SF-12 Physical Component Summary (PCS) score
Tidsramme: Baseline and 4 weeks (immediately before and after the 4-week training program)
Physical component summary score of the 12-item Short Form Health Survey. Scores are norm-based to a population mean of 50 with a standard deviation of 10. Higher scores indicate better physical health-related quality of life.
Baseline and 4 weeks (immediately before and after the 4-week training program)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. januar 2025

Primær fullføring (Faktiske)

31. desember 2025

Studiet fullført (Faktiske)

30. juli 2026

Datoer for studieregistrering

Først innsendt

4. august 2026

Først innsendt som oppfylte QC-kriteriene

9. august 2026

Først lagt ut (Faktiske)

12. august 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

12. august 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

9. august 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

De-identified individual participant data underlying the published results, including baseline characteristics and pre- and post-intervention values for all primary and secondary outcome measures, will be made available to qualified investigators upon reasonable request to the corresponding author.

IPD-delingstidsramme

Beginning 6 months after publication, with no end date

Tilgangskriterier for IPD-deling

Requests will be reviewed by the study investigators. Requesting investigators must provide a methodologically sound proposal and a signed data access agreement. Approval of the institutional review board may be required.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere